Gossamer Bio Inc (NASDAQ:GOSS) concluded the trading at $1.35 on Friday, March 22, with a rise of 2.27% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $1.32 and 5Y monthly beta was reading 1.72. Considering stock’s 52-week price range provides that GOSS hit a high price of $1.88 and saw its price falling to a low level of $0.45 during that period. Over a period of past 1-month, stock came adding 16.38% in its value.
With its current market valuation of $304.53 million, Gossamer Bio Inc is set to declare its quarterly results on May 07, 2024 – May 13, 2024. Analysts are in estimates of -$0.18 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$0.74 for 2024 with estimates of that growing to -$0.69 in next year. These estimates are suggesting current year growth of 37.30% for EPS and 6.80% growth next year.
In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review GOSS stock’s current outlook then short term indicators are assigning it an average of 50% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Long term indicators are suggesting an average of 50% Buy for it.
Digging deeper we become aware of the PEG ratio of the GOSS stock which is currently positioned at 0. It further provides that stock’s current price level is -2.17% away from its 20-day simple moving average and is 22.21% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 54.80 while volatility remained at 7.86% over the past week which changes to 9.88% when measuring it over the past month. Beta is valued at 1.72, while measure of average true range or ATR is currently at 0.12.
Having a second look at Gossamer Bio Inc (NASDAQ:GOSS) provides that stock’s average daily trading volume for 3 months was 1.07 million, while it jumped to 1.51 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 225.41 million.
The percentage of outstanding shares held by the insiders is 16.30% while it is 79.44% for the institutional holders. The figures also indicate that as of Feb 29, 2024, number of stock’s short shares was 14.3 million which implies a short ratio of 11.54. This shows down a 6.34% of Short Interest in company’s outstanding shares on the day. In February the standing of shares short improved as it was 16.72 million in the previous month. Addition of 47.95% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
